In the realm of science, researchers have long struggled to target the elusive "intrinsically disordered proteins," which play…
Summary: Diakonos Oncology Corp. closed a $20m private placement of Simple Agreements for Future Equity (SAFE) to develop…
Summary: Remedy Plan Therapeutics, a pharmaceutical company in Gaithersburg, MD, secured $18M in funding for developing new NAMPT…
Sign in to your account